May 10, 2013 at 07:39 AM EDT
S&P Highlights Biotech ETFs
Bolstered by an accommodating Food & Drug Administration and promising recent clinical results for drugs aimed at treating conditions such as hepatitis C and multiple sclerosis, biotechnology stocks and ETFs have been stellar performers in 2013. Recently, it was an announcement by Vertex (NASDAQ: VRTX ) that its cystic fibrosis
ABBOTT LABORATORIES Amgen, Inc. Biogen Idec, Inc. Celgene Corp Gilead Sciences, Inc. Johnson & Johnson MARKET VECTORS BIOTECH ETF NPS Pharmaceuticals, Inc. NewStar Financial, Inc. POWERSHARES DYNAMIC PHARMACEUTICALS PORTFOLIO SPDR S&P BIOTECH ETF Sprint Nextel Vertex Pharmaceuticals, Inc. iShares Nasdaq Biotechnology Index Fund
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here